Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CLONAZEPAM Cause Obstructive airways disorder? 214 Reports in FDA Database

Sharpen Your Memory & Focus Naturally

NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.

Boost Your Brain

According to the FDA Adverse Event Reporting System (FAERS), 214 reports of Obstructive airways disorder have been filed in association with CLONAZEPAM (Clonazepam). This represents 0.5% of all adverse event reports for CLONAZEPAM.

214
Reports of Obstructive airways disorder with CLONAZEPAM
0.5%
of all CLONAZEPAM reports
2
Deaths
176
Hospitalizations

How Dangerous Is Obstructive airways disorder From CLONAZEPAM?

Of the 214 reports, 2 (0.9%) resulted in death, 176 (82.2%) required hospitalization, and 17 (7.9%) were considered life-threatening.

Is Obstructive airways disorder Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CLONAZEPAM. However, 214 reports have been filed with the FAERS database.

What Other Side Effects Does CLONAZEPAM Cause?

Drug ineffective (5,088) Toxicity to various agents (4,028) Completed suicide (3,320) Drug abuse (3,287) Off label use (2,590) Anxiety (2,376) Somnolence (2,260) Dyspnoea (1,987) Depression (1,838) Insomnia (1,836)

What Other Drugs Cause Obstructive airways disorder?

ALBUTEROL (4,195) TIOTROPIUM (2,634) PREDNISONE (2,480) BUDESONIDE\FORMOTEROL (2,210) MONTELUKAST (2,073) MEPOLIZUMAB (1,883) OMALIZUMAB (1,670) CICLESONIDE (1,403) FLUTICASONE\SALMETEROL (1,253) BUDESONIDE (1,214)

Which CLONAZEPAM Alternatives Have Lower Obstructive airways disorder Risk?

CLONAZEPAM vs CLONIDINE CLONAZEPAM vs CLOPIDOGREL CLONAZEPAM vs CLOPIDOGREL BESILATE CLONAZEPAM vs CLOPIDOGREL BISULFATE CLONAZEPAM vs CLORAZEPATE

Related Pages

CLONAZEPAM Full Profile All Obstructive airways disorder Reports All Drugs Causing Obstructive airways disorder CLONAZEPAM Demographics